| Literature DB >> 26696889 |
Yifat Glikmann-Johnston1, Michael M Saling2, David C Reutens3, Julie C Stout4.
Abstract
Spatial cognition is fundamental for survival in the topographically complex environments inhabited by humans and other animals. The hippocampus, which has a central role in spatial cognition, is characterized by high concentration of serotonin (5-hydroxytryptamine; 5-HT) receptor binding sites, particularly of the 1A receptor (5-HT1A) subtype. This review highlights converging evidence for the role of hippocampal 5-HT1A receptors in spatial learning and memory. We consider studies showing that activation or blockade of the 5-HT1A receptors using agonists or antagonists, respectively, lead to changes in spatial learning and memory. For example, pharmacological manipulation to induce 5-HT release, or to block 5-HT uptake, have indicated that increased extracellular 5-HT concentrations maintain or improve memory performance. In contrast, reduced levels of 5-HT have been shown to impair spatial memory. Furthermore, the lack of 5-HT1A receptor subtype in single gene knockout mice is specifically associated with spatial memory impairments. These findings, along with evidence from recent cognitive imaging studies using positron emission tomography (PET) with 5-HT1A receptor ligands, and studies of individual genetic variance in 5-HT1A receptor availability, strongly suggests that 5-HT, mediated by the 5-HT1A receptor subtype, plays a key role in spatial learning and memory.Entities:
Keywords: 5-HT1A receptor; hippocampus; memory; serotonin; spatial cognition
Year: 2015 PMID: 26696889 PMCID: PMC4674558 DOI: 10.3389/fphar.2015.00289
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Figure 1Schematic illustration of brain areas involved in spatial memory (.
Summary of the studies cited according to the experimental method used.
| Knockout mouse models | Sarnyai et al., | 5-HT1A-deficient mice were impaired on the Morris water maze and the “Y” shape maze. |
| Wolff et al., | Young-adults, but not aged, 5-HT1A knockouts exhibited an impairment of learning and retention of the Morris water maze. | |
| 5-HT1A receptor stimulation | Micheau and Van Marrewijk, | Intra-peritoneal administration of 8-OH-DPAT |
| Bertrand et al., | Intra-septal injection of 8-OH-DPAT significantly impaired spatial learning in a water maze task. | |
| Warburton et al., | Effects of 8-OH-DPAT on the rat performance of the Delayed Non-Matching to Position task varied according to the site of administration. In the dorsal raphe, the compound had no effect at any dose. Administration into the median raphe improved performance accuracy. In the dorsal hippocampus, 8-OH-DPAT produced a small impairment in performance. | |
| Carli et al., | Rats treated subcutaneously with 8-OH-DPAT were impaired in choice accuracy on a two-platform spatial discrimination task. Spiroxatrine and (+)WAY100135 | |
| Egashira et al., | Bilateral microinjections of 8-OH-DPAT into rats' dorsal hippocampus impaired spatial memory on the eight-arm radial maze. WAY-100135 and NAN-190 | |
| Olsen et al., | Chronic treatment with buspirone | |
| Cheng et al., | Delayed and chronic treatment regimen with 8-OH-DPAT after cortical impact injury in rats facilitated motor recovery and acquisition of spatial learning in a water maze task. | |
| Monaco et al., | A combined therapeutic regimen of buspirone and environmental enrichment was more effective than either alone in enhancing spatial learning in brain injured pediatric rats. | |
| Imaging serotonergic neurotransmission | Glikmann-Johnston et al., | Hippocampal asymmetry in PET [18F]MPPF binding was associated with performance on a virtual object-location task. A lower binding potential in the right vs. the left hippocampus was related to better memory performance. |
| Theodore et al., | Using the PET ligand 18FCWAY, reduced left hippocampal 5-HT1A receptor binding in temporal lobe epilepsy patients was related to delayed auditory verbal memory impairment, independent of the side of the epileptic focus. | |
| Genetic variance in 5-HT1A receptor availability | Roiser et al., | MDMA |
| Roiser et al., | Carriers of the | |
| Jedema et al., | Rhesus monkeys who are | |
| Manipulations of 5-HT levels | du Jardin et al., | PCPA |
| Fox et al., | Heavy MDMA users were impaired on several spatial memory components as tested by the CANTAB, including pattern recognition and spatial working memory. | |
| Skelton et al., | MDMA-treated rats showed long lasting spatial learning deficits on the Morris water maze. Their performance on the Cincinnati water maze, a test of path integration learning, was initially impaired, but recovered over time. | |
| Vorhees et al., | MDMA dose distribution had a long-term differential effect on different types of spatial learning. Path integration was mostly impaired following administration of a single dose. Spatial learning and reference memory was significantly impaired following administration of four divided doses. | |
| Fisk et al., | Current and previous MDMA use was associated with visuospatial working memory impairment. | |
| Morford et al., | Neonatal rats treated with D-fenfluramine | |
| Vorhees et al., | Rats exposed to methamphetamine | |
| Vorhees et al., | Neonatal methamphetamine treatment in rats produced selective spatial learning and memory deficits on the Morris water maze during adulthood. | |
| Vorhees et al., | Methamphetamine treatment in rats impaired path integration learning irrespective of dose. Only high doses of the drug impaired rats' spatial learning and memory performance on the Morris water maze. Enrichment of rearing conditions significantly improved acquisition of the task. | |
| Schröder et al., | A neurotoxic regimen of methamphetamine rats induced damage to 5-HT terminals, as indicated by decreased [125I]RTI-55 binding in the hippocampus, and impaired performance on an object recognition task, but not performance in the Morris water maze. |
8-OH-DPAT is a 5-HT.
Spiroxatrine and (+)WAY100135 are 5-HT.
NAN-190 is a 5-HT.
Buspirone is a 5-HT.
Acute effects of MDMA include a rapid and significant increase in 5-HT, released from presynaptic vesicular stores. Repeated and high doses of MDMA cause decreased concentrations of 5-HT and its metabolite 5-HIAA.
The S allele at the 5-HTTLPR is associated with reduced serotonergic neurotransmission relative to the L allele.
Parachlorophenylalanine (PCPA) inhibits tryptophan hydroxylase, and thus reduces 5-HT synthesis.
Flesinoxan is a selective 5-HT.
D-fenfluramine is a substituted amphetamine that induces 5-HT release and inhibits its reuptake. Initially, D-fenfluramine increases 5-HT extracellular concentrations, but later causes a significant depletion.
Methamphetamine induces long-lasting reductions of dopamine and 5-HT, inhibits presynaptic neurotransmitter reuptake, and reduces tyrosine and tryptophan hydroxylase activities.